Lotus Pharmaceutical's latest marketcap:
As of 08/11/2025, Lotus Pharmaceutical's market capitalization has reached $1.94 B. According to our data, Lotus Pharmaceutical is the 6468th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.94 B |
| Revenue (ttm) | 638.86 M |
| Net Income (ttm) | 182.63 M |
| Shares Out | 261.75 M |
| EPS (ttm) | 0.69 |
| Forward PE | 11.11 |
| Ex-Dividend Date | 08/11/2025 |
| Earnings Date | 08/07/2025 |
Lotus Pharmaceutical's yearly market capitalization.
| Date | Market Cap(NT$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/11/2025 | NT$57.98 B | $1.94 B | -18.94% | 6468 |
| 12/31/2024 | NT$71.52 B | $2.18 B | -0.57% | 5374 |
| 12/29/2023 | NT$71.94 B | $2.34 B | 11.59% | 5090 |
| 12/30/2022 | NT$64.46 B | $2.1 B | 152.11% | 5194 |
| 12/30/2021 | NT$25.57 B | $922.27 M | 30.27% | 9773 |
| 12/31/2020 | NT$19.63 B | $697.79 M | -29.79% | 9786 |
| 12/31/2019 | NT$27.96 B | $933.24 M | 58.4% | 7123 |
| 12/28/2018 | NT$17.65 B | $576.47 M | 45.29% | 8408 |
| 12/29/2017 | NT$12.15 B | $408.79 M | -14.86% | 11376 |
| 12/30/2016 | NT$14.27 B | $439.18 M | -13.81% | 9899 |
Company Profile
About Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. is a leading company specializing in the research, development, manufacturing, and sale of generic pharmaceutical products. Headquartered in Taipei City, Taiwan, the company operates globally, serving markets in Taiwan, South Korea, the United States, and other international regions.
Product Portfolio
The company offers a diverse range of generic pharmaceuticals, with a focus on key therapeutic areas, including:
- Oncology
- Cardiology
- Nephrology
- Women's Health
- Anti-Obesity
- Central Nervous System Diseases
Additionally, Lotus Pharmaceutical provides over-the-counter (OTC) healthcare products to meet consumer needs.
Services and Operations
Beyond pharmaceuticals, the company offers a variety of services, such as:
- Retail of clinical machines
- Biotech technological consulting
- Pharmaceutical and medicinal chemical product sales
- Marketing and market planning services
- Health management and technology consultancy
- Pharmaceutical regulatory affairs project management
- Contract research organization (CRO) services
Strategic Partnerships
Lotus Pharmaceutical has established a strategic partnership with NRX Pharmaceuticals, enhancing its capabilities in drug development and market expansion.
Company Background
Founded in 1966, Lotus Pharmaceutical Co., Ltd. has grown into a trusted name in the generic pharmaceutical industry, committed to delivering high-quality healthcare solutions worldwide.
Frequently Asked Questions
-
What is Lotus Pharmaceutical's (TPE-1795) current market cap?As of 08/11/2025, Lotus Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $1.94 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Lotus Pharmaceutical (TPE-1795) rank globally by market cap?Lotus Pharmaceutical global market capitalization ranking is approximately 6468 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.